Schrödinger To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday
Portfolio Pulse from Lisa Levin
Several analyst forecasts were released on Thursday, with price target changes for multiple companies. Keybanc raised the price target for Micron Technology from $70 to $80, while Credit Suisse cut Pfizer's price target from $47 to $40. Pivotal Research reduced Liberty Global's price target from $30 to $25, and Keefe, Bruyette & Woods increased Green Dot Corporation's price target from $17 to $20. Goldman Sachs cut Foghorn Therapeutics' price target from $21 to $19, and HC Wainwright & Co. raised Roivant Sciences' price target from $15 to $18. Morgan Stanley increased Schrödinger's price target from $38 to $52, and UBS raised Symbotic's price target from $34 to $40. Morgan Stanley lowered General Mills' price target from $77 to $72, and B of A Securities increased The RealReal's price target from $1 to $1.85. Finally, Keybanc raised Invitation Homes' price target from $35 to $37.
June 29, 2023 | 12:53 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Goldman Sachs cut Foghorn Therapeutics' price target from $21 to $19.
The reduced price target by Goldman Sachs indicates a negative outlook for Foghorn Therapeutics, which could lead to a decrease in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Morgan Stanley lowered General Mills' price target from $77 to $72.
The reduced price target by Morgan Stanley indicates a negative outlook for General Mills, which could lead to a decrease in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Pivotal Research reduced Liberty Global's price target from $30 to $25.
The reduced price target by Pivotal Research indicates a negative outlook for Liberty Global, which could lead to a decrease in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Credit Suisse cut Pfizer's price target from $47 to $40.
The reduced price target by Credit Suisse indicates a negative outlook for Pfizer, which could lead to a decrease in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Keefe, Bruyette & Woods increased Green Dot Corporation's price target from $17 to $20.
The increased price target by Keefe, Bruyette & Woods indicates a positive outlook for Green Dot Corporation, which could lead to an increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Keybanc raised Invitation Homes' price target from $35 to $37.
The increased price target by Keybanc indicates a positive outlook for Invitation Homes, which could lead to an increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Keybanc raised the price target for Micron Technology from $70 to $80.
The raised price target by Keybanc indicates a positive outlook for Micron Technology, which could lead to an increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
B of A Securities increased The RealReal's price target from $1 to $1.85.
The increased price target by B of A Securities indicates a positive outlook for The RealReal, which could lead to an increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
HC Wainwright & Co. raised Roivant Sciences' price target from $15 to $18.
The increased price target by HC Wainwright & Co. indicates a positive outlook for Roivant Sciences, which could lead to an increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Morgan Stanley increased Schrödinger's price target from $38 to $52.
The increased price target by Morgan Stanley indicates a positive outlook for Schrödinger, which could lead to an increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
UBS raised Symbotic's price target from $34 to $40.
The increased price target by UBS indicates a positive outlook for Symbotic, which could lead to an increase in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100